General Information of the Cell Line
Cell Line ID
CL001060
Cell Line Name
123.7
Category
Cancer cell line
Organism
Rattus norvegicus (Rat)
Tissue Information
Adrenal gland
Disease
Rat adrenal gland pheochromocytoma (NCIt: C121568)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT02273, Vesicular acetylcholine transporter
Compound ID Compound Name Compound Formula
CP0200171
(+)-1''-(3-Iodo-benzyl)-4-phenyl-[1,3'']bipiperidinyl-4''-ol
   Show/Hide
C23H29IN2O
 1
1
Ki = 0.13 nM
   TI
   LI
   LO
   TS
CP0207181
(3'R,4'R)-1'-(4-Fluoro-benzyl)-4-phenyl-[1,3']bipiperidinyl-4'-ol
   Show/Hide
C23H29FN2O
 1
1
Ki = 0.22 nM
   TI
   LI
   LO
   TS
CP0045885
(1R,2R)-2-(4-Phenyl-piperidin-1-yl)-cyclohexanol
   Show/Hide
C17H25NO
 1
1
Ki = 4.4 nM
   TI
   LI
   LO
   TS
CP0451532
(1R,2R)-2-[4-(4-methylphenyl)piperidin-1-yl]cyclohexan-1-ol
   Show/Hide
C18H27NO
 1
1
Ki = 22.9 nM
   TI
   LI
   LO
   TS
CP0494571
[1-[(3S,4S)-1-benzyl-4-hydroxypiperidin-3-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C25H32N2O3
 1
1
Ki = 35.5 nM
   TI
   LI
   LO
   TS
CP0472821
[1-[(3S,4S)-1-benzyl-3-hydroxypiperidin-4-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C25H32N2O3
 1
1
Ki = 44.2 nM
   TI
   LI
   LO
   TS
CP0504901
[1-[(3S,4S)-1-[(4-fluorophenyl)methyl]-4-hydroxypiperidin-3-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C25H31FN2O3
 1
1
Ki = 48.6 nM
   TI
   LI
   LO
   TS
CP0490189
[1-[(3S,4S)-4-hydroxy-1-(pyridin-3-ylmethyl)piperidin-3-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C24H31N3O3
 1
1
Ki = 107 nM
   TI
   LI
   LO
   TS
CP0452454
(4-fluorophenyl)-[1-[(3S,4S)-1-[(4-fluorophenyl)methyl]-4-hydroxypiperidin-3-yl]piperidin-4-yl]methanone
   Show/Hide
C24H28F2N2O2
 1
1
Ki = 136 nM
   TI
   LI
   LO
   TS
CP0424933
[1-[(3S,4S)-3-hydroxy-1-(pyridin-3-ylmethyl)piperidin-4-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C24H31N3O3
 1
1
Ki = 137 nM
   TI
   LI
   LO
   TS
CP0504899
[1-[(3S,4S)-1-benzyl-4-hydroxypiperidin-3-yl]piperidin-4-yl]-(4-fluorophenyl)methanone
   Show/Hide
C24H29FN2O2
 1
1
Ki = 149 nM
   TI
   LI
   LO
   TS
CP0504900
(4-fluorophenyl)-[1-[(3S,4S)-4-hydroxy-1-(pyridin-3-ylmethyl)piperidin-3-yl]piperidin-4-yl]methanone
   Show/Hide
C23H28FN3O2
 1
1
Ki = 237 nM
   TI
   LI
   LO
   TS
CP0296558
[1-[(3S,4S)-1-[(4-fluorophenyl)methyl]-3-hydroxypiperidin-4-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C25H31FN2O3
 1
1
Ki = 294 nM
   TI
   LI
   LO
   TS
CP0452453
[1-[(3S,4S)-3-hydroxy-1-(pyridine-3-carbonyl)piperidin-4-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C24H29N3O4
 1
1
Ki = 372 nM
   TI
   LI
   LO
   TS
CP0424932
[1-[(3S,4S)-1-benzyl-3-hydroxypiperidin-4-yl]piperidin-4-yl]-(4-fluorophenyl)methanone
   Show/Hide
C24H29FN2O2
 1
1
Ki = 401 nM
   TI
   LI
   LO
   TS
CP0504905
[1-[(3S,4S)-1-benzoyl-3-hydroxypiperidin-4-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C25H30N2O4
 1
1
Ki = 555 nM
   TI
   LI
   LO
   TS
CP0505484
[1-[(3S,4S)-1-benzoyl-3-hydroxypiperidin-4-yl]piperidin-4-yl]-(4-fluorophenyl)methanone
   Show/Hide
C24H27FN2O3
 1
1
Ki = 683 nM
   TI
   LI
   LO
   TS
CP0460030
[1-[(3S,4S)-4-hydroxy-1-[(4-methoxyphenyl)methyl]piperidin-3-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C26H34N2O4
 1
1
Ki = 1080 nM
   TI
   LI
   LO
   TS
CP0272134
(4-fluorophenyl)-[1-[(3S,4S)-1-[(4-fluorophenyl)methyl]-3-hydroxypiperidin-4-yl]piperidin-4-yl]methanone
   Show/Hide
C24H28F2N2O2
 1
1
Ki = 1360 nM
   TI
   LI
   LO
   TS
CP0389911
(4-fluorophenyl)-[1-[(3S,4S)-4-hydroxy-1-[(4-methoxyphenyl)methyl]piperidin-3-yl]piperidin-4-yl]methanone
   Show/Hide
C25H31FN2O3
 1
1
Ki = 1970 nM
   TI
   LI
   LO
   TS
CP0451535
(4-fluorophenyl)-[1-[(3S,4S)-3-hydroxy-1-(pyridin-3-ylmethyl)piperidin-4-yl]piperidin-4-yl]methanone
   Show/Hide
C23H28FN3O2
 1
1
Ki = 2030 nM
   TI
   LI
   LO
   TS
CP0389910
(4-fluorophenyl)-[1-[(3S,4S)-3-hydroxy-1-[(4-methoxyphenyl)methyl]piperidin-4-yl]piperidin-4-yl]methanone
   Show/Hide
C25H31FN2O3
 1
1
Ki = 3310 nM
   TI
   LI
   LO
   TS
CP0529497
(4-fluorophenyl)-[1-[(3S,4S)-3-hydroxy-1-(pyridine-3-carbonyl)piperidin-4-yl]piperidin-4-yl]methanone
   Show/Hide
C23H26FN3O3
 1
1
Ki = 3340 nM
   TI
   LI
   LO
   TS
CP0472822
[1-[(3S,4S)-1-(4-fluorobenzoyl)-3-hydroxypiperidin-4-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C25H29FN2O4
 1
1
Ki = 3460 nM
   TI
   LI
   LO
   TS
CP0504904
[1-[(3S,4S)-1-(4-fluorobenzoyl)-3-hydroxypiperidin-4-yl]piperidin-4-yl]-(4-fluorophenyl)methanone
   Show/Hide
C24H26F2N2O3
 1
1
Ki = 3600 nM
   TI
   LI
   LO
   TS
CP0460029
[1-[(3S,4S)-3-hydroxy-1-[(4-methoxyphenyl)methyl]piperidin-4-yl]piperidin-4-yl]-(4-methoxyphenyl)methanone
   Show/Hide
C26H34N2O4
 1
1
Ki = 14800 nM
   TI
   LI
   LO
   TS
CP0511423
(4-fluorophenyl)-[1-[(3S,4S)-3-hydroxy-1-(4-methoxybenzoyl)piperidin-4-yl]piperidin-4-yl]methanone
   Show/Hide
C25H29FN2O4
 1
1
Ki = 30900 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Adrenal gland)
Cell Line Name Organism Disease
NCI-H295R Homo sapiens (Human) Adrenal cortex carcinoma
SW13 Homo sapiens (Human) Adrenal cortex carcinoma
Y1 Mus musculus (Mouse) Mouse adrenal cortical carcinoma
PC12 Rattus norvegicus (Rat) Rat adrenal gland pheochromocytoma
CAD Mus musculus (Mouse) -